Keros Therapeutics (KROS) Assets Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.12% |
| Sep 30, 2025 | 28.23% |
| Jun 30, 2025 | 66.40% |
| Mar 31, 2025 | 61.49% |
| Dec 31, 2024 | 66.44% |
| Sep 30, 2024 | 77.56% |
| Jun 30, 2024 | 27.71% |
| Mar 31, 2024 | 26.37% |
| Dec 31, 2023 | 20.62% |
| Sep 30, 2023 | 29.18% |
| Jun 30, 2023 | 57.20% |
| Mar 31, 2023 | 63.49% |
| Dec 31, 2022 | 20.19% |
| Sep 30, 2022 | 9.82% |
| Jun 30, 2022 | -6.90% |
| Mar 31, 2022 | -8.76% |
| Dec 31, 2021 | -5.27% |
| Sep 30, 2021 | 66.34% |
| Jun 30, 2021 | 61.83% |
| Mar 31, 2021 | 325.35% |
| Dec 31, 2020 | 2,359.54% |